Actinium Pharmaceuticals, Inc. financial data

Symbol
ATNM on NYSE
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 843% % -13%
Debt-to-equity 190% % 72%
Return On Assets -52% % -9.2%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 31,195,891 shares 0%
Common Stock, Shares, Outstanding 31,195,891 shares 0%
Entity Public Float $226,015,477 USD 13%
Common Stock, Value, Issued $31,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 31,195,891 shares 0.4%
Weighted Average Number of Shares Outstanding, Diluted 31,195,891 shares 0.4%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $90,000 USD
Research and Development Expense $21,638,000 USD -35%
General and Administrative Expense $15,790,000 USD 35%
Operating Income (Loss) $37,338,000 USD 17%
Nonoperating Income (Expense) $2,739,000 USD -32%
Net Income (Loss) Attributable to Parent $34,599,000 USD 15%
Earnings Per Share, Basic -1 USD/shares 21%
Earnings Per Share, Diluted -1 USD/shares 21%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $53,391,000 USD -32%
Other Assets, Current $357,000 USD 58%
Assets, Current $54,366,000 USD -32%
Property, Plant and Equipment, Net $226,000 USD -45%
Operating Lease, Right-of-Use Asset $1,215,000 USD -34%
Assets $56,151,000 USD -32%
Liabilities, Current $6,834,000 USD -12%
Contract with Customer, Liability, Noncurrent $35,000,000 USD 0%
Operating Lease, Liability, Noncurrent $531,000 USD -53%
Liabilities $42,367,000 USD -3.5%
Retained Earnings (Accumulated Deficit) $403,773,000 USD -9.4%
Stockholders' Equity Attributable to Parent $13,784,000 USD -64%
Liabilities and Equity $56,151,000 USD -32%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $7,574,000 USD -2.7%
Net Cash Provided by (Used in) Financing Activities $14,768,000 USD 1818%
Net Cash Provided by (Used in) Investing Activities $11,000 USD 86%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 31,195,891 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $53,723,000 USD -32%
Deferred Tax Assets, Valuation Allowance $101,613,000 USD 12%
Operating Lease, Liability $1,415,000 USD -28%
Payments to Acquire Property, Plant, and Equipment $11,000 USD -86%
Lessee, Operating Lease, Liability, to be Paid $1,498,000 USD -29%
Operating Lease, Liability, Current $599,000 USD 9.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $380,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid, Year One $643,000 USD 38%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $83,000 USD -50%
Lessee, Operating Lease, Liability, to be Paid, Year Three $380,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $47,875,000 USD 15%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $380,000 USD
Operating Lease, Payments $156,000 USD 2%
Additional Paid in Capital $417,526,000 USD 2.5%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $205,000 USD -5.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%